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Abstract: Ten plants indigenous to Sudan and of common use in Sudanese folk-medicine, were examined in vitro for antimalarial activity 
against schizonts maturation of Plasmodium falciparum, the major human malaria parasite. All plant samples displayed various anti-
plasmodial activity. Three plant extracts caused 100% inhibition of the parasite growth at concentrations of plant material  500 ug/ml. 
The two most active extracts that produced 100% inhibition of the parasite growth at concentration of plant material  50 µg/ml were 
obtained from the seeds of Nigella sativa and the whole plant of Aristolochia bracteolata. The ten plants were phytochemically screened 
for their active constituents. The two most active plants showed the presence of sterols, alkaloids and tannins. 
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Introduction
Malaria, a mosquito-borne disease is global. It was 
estimated that there were over 300 million cases of 
malaria every year in developing countries especially 
in  Africa  Sub-sahara  (90%)  and  other  developing 
countries.  Malaria  kills  over  one  million  people  a 
year-mainly children under five years and pregnant 
women.1 Malaria is a major health problem in Sudan. 
It constitutes 30% of all attendance to health facilities. 
It is the main cause of hospital death and the failure of 
malaria control is largely due to the increasing para-
site resistance to chloroquine and vector resistance to 
insecticides used.2
In all malaria endemic countries, plants are used 
in traditional medicine for treatment of the disease. 
Examples are numerous with the urgent need to develop 
new, safe and effective drugs against malaria. Plants 
may provide such drugs directly as with quinine from 
Cinchona bark or artemisinine from the Chinese herb 
Artemisia annua and/or they may provide template 
molecules on which to base further novel structures 
by organic synthesis.3
In  Sudan,  out  of  21  compounds  isolated  from 
9 medicinal plants used in traditional medicine, only 
gedunin and quercetin showed IC50 of 1 µM as anti-
plasmodial activity when tested in vitro against Plas-
modium falciparum.4 Moreover, an investigation of 
antiplasmodial activity of selected Sudanese plants 
revealed that most plants from the family. Meliaceae 
showed highly potent antiplasmodial activity against 
the  two  tested  strains  (3D7-chloroquine  and  pyri-
methamine sensitive and Dd2-chloroquine resistant 
and pyrimethamine sensitive Plasmodium falciparum 
strains).  Khaya  senegalensis  (Mahogany),  Azadi-
rachta indica (Neem) and Trichilia emetic (Dabkar) 
showed 1C50 values less than 5 µg/ml.5
The  present  study  was  carried  out  to  screen 
10  plant  samples,  representing  10  species  and 
9  families,  for  their  antiplasmodial  activity  and 
phytoconstituents.
Materials and Methods
Plant material
Plants used for this study were kindly supplied by 
the Medicinal and Aromatic Herbs Research Insti-
tute of the National Council for Research, khartoum 
(Table 1).
Extraction method
Twenty grams of dried and coarsely powdered plant 
materials were extracted by maceration in a conical 
flask for 24 hours using petroleum ether/chloroform 
(1:1) and continuous shaking.6
Each extract was first filtered, then was concentrated 
by evaporation under vacuum at 60 °C using a rotary 
evaporator to give 20 ml (1 g of plant material/ml crude 
extract) and kept in a refrigerator until use (for easy 
calculation and practical procedure).
Preparation of working solution
The required concentration corresponding to 10, 100 
and  1000  µg/ml  was  taken  from  the  concentrated 
extract and evaporated to dryness and were prepared 
in complete medium (RPMI 1640 Invetrogen, UK + 
10% human serum), on the day of the test.5
Phytochemical methods
Phytochemical  screening  for  the  secondary  plant 
constituents present in the plant extracts was carried 
out using methods adopted in similar surveys.6 This 
quantitative  and  phytochemical  analysis  of  the  10 
plants was determined as follows: Sterols and terpe-
noids (Lieberman’s—Burchard’s reaction; alkaloids 
(Mayor’s/Wagner’s/Dragendroff’s  reagents);  flavo-
noids (conc Hcl + magnesium ribbon); cardiac gly-
cosoides  (Keller—Kiliani  test);  tannin  (Fecl3  test); 
saponins  (frothing  test);  cyanogenic  glycosides 
(sodium picrate paper); anthraquinone (5 g plant mate-
rial in 20 ml 20% H2SO4 and 2 ml 2% Fecl3, refluxed 
for 30 minutes, cooled, filtered and extracted with 
CHcl3 + 5 ml 10% ammonium hydroxide. Pink—red 
colour in the alkaline layer indicated the presence of 
anthraquinones).
Parasite cultivation and in vitro testing
In vitro testing of extracts were carried out accord-
ing to the method recommended by WHO.7 In this 
method, sterile heparinized capillary tube was used to 
take blood samples (isolate) from patients with symp-
tomatic malaria and who had not recently received 
antimalarial drug and who had mono-infection with 
Plasmodium falciparum and asexual parasitaemias in 
excess of 1000 parasites but less than 80.000 parasite 
per uL blood. The sample was maintained in blood-
medium mixture BMM (1:9), i.e. each 100 uL blood sudanese antiplasmodial medicinal plants
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sample (isolate) required 0.9 ml of RPMI 1640 liquid 
medium to make a total of 1 ml BMM.
The unpredosed wells (12/plate) of tissue culture 
plates (WHO, in vitro microtest plate. VCRU, USM, 
Malaysia),  were  dosed  with  50  u  µ  I  of  prepared 
working solution of drugs of 10,100 and 1000 µg/ml 
separately 50 µl of the BMM were added to each well 
using fixed volume Eppendrof pipette and a disposable 
sterile tip. The resultant testing solutions were diluted 
thereafter by the addition of equal volume of BMM 
to give: 5, 50 and 500 µg/ml. Dosing of wells with 
BMM was always done starting with control wells. 
Chloroquine (standard) tested concomitantly on each 
occasion. Blood/drug concentration was mixed well 
by shaking plates gently. Plates were then placed in 
candle Jar with candle on. The candle Jar was closed 
when the candle is about to go off. The candle jar was 
then placed in an incubator at 37 °C for 42 hours. 
At the end of the incubation period, the tissue culture 
plates were removed and placed on a clean bench. 
The  supernatant  was  removed  using  glass  Pasteur 
pipette and the red blood cells deposited at the bottom 
were mixed and transferred to a glass slide. Smears 
were made and stained with 1% Giemsa in phosphate 
buffer, pH 7.2 for 30 minutes, then dried and exam-
ined under the microscope. Schizonts containing 3 or 
more merozoites per 200 trophozoites were enumer-
ated, they were considered successful if 10% of the 
parasites in the control well developed into schizonts. 
The highest drug concentration at which no schizonts 
grow was considered to be the end point value for the 
test. Each extract was evaluated in triplicate, and the 
mean was calculated as follows:
a. Maturation percentage =
No. of developed schizonts for test       × 100
No. of developed schizonts for control
Table . Plants screened for their antiplasmodial activity and phytoconstituents.
Botanical name and  
(family) 
Local name   Folk use Morphological  
part tested
Geographical 
source
Aerva javanica 
(Amaranthaceae)
Um-shariaa Forfevers and to relief  
intestinal gases
WP Khs
Ambrosia 
maritima 
(Asteraceae)
Damsisa Anti-inflammatory in kidney 
diseases, diabetes mellitus  
and malaria
WP Khs
Aristolochia 
bracteolata  
(Aristolochiaceae)
Um galagel roots used fo scorpion stings  
and anti-inflammator, leaves  
for malaria
WP Khs
Citrullus 
colocynthis  
(cucurbitaceae)
El-Handal For haemoroids, arthiritis,  
eczema, laxative and  
for malaria
s gs
Croton zambesicus 
(Euphorbiaceae)
Um-geleigla Anti-hypertensive and  
for malaria
Fr cs
Gardenia lutea 
(rubiacene)
Um gawy Fruit is eaten by human FrP Khs
Puliearia crispa 
(Asteraceae)
El-rmeit As a source of essential oil WP Khs
Nigella sativa 
(ranuneulaceae)
Kamun-Aswad  
Habat ElBaraka
Anti-inflamatory, allergies,  
eczema and for malaria
s ns
Solenostema argel 
(Ascepiadaceae)
El-Hargel carminative,  
Antispasmodic and for malaria
L ns
Tinospora bakis 
(Menispermaceae)
Erg-El-Hagar For fevers, diarrhoea  
and dysentery
WP cs
Abberviations: L, leaf; WP, Whole plant; Fr, Fruit; FrP, Fruit Pulp; s, seed; Kh s, Khartoum state; gs, gezira state; cs, central sudan; ns, northern 
state.Ahmed et al
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b. Inhibition percentage = 100-maturation percentage.
statistical method
The collected data were analyzed using one—way 
ANOVA.
Ethical approval
The ethical approval for this study was obtained from 
the Ethical Committee of the Blue Nile Research and 
Training Institute/University of Gezira (Wad Medani, 
Sudan) and from Gezira State Ministry of Health.
Results
Antiplasmodial activity
Table 2 shows the effects of extracts from 10 Sudanese 
medicinal plants on schizonts maturation of Plasmo-
dium falciparum.
It was shown that, at plant material concentration 
5 µg/ml, six plant extracts were found to possess 
more  than  50%  inhibition  of  the  parasite  growth; 
these are: Ambrosia maritime, Aristolochia bracteo-
lata,  Citrullus  colocnthis,  Gardenia  lutea,  Nigella 
sativa and Solenostema argel. All plant extracts tested 
showed  50%  inhibition  of  the  parasite  at  plant 
material concentration 50 µg/ml. Aerva javanica, 
whole plant, caused 100% inhibition of the parasite 
growth at the incubation concentration 500 µg/ml. 
The  two  most  active  extracts  that  produced  100% 
inhibition of the parasite growth at plant material con-
centration 50 µg/ml were obtained from the seeds 
of Nigella sativa and the whole plant of Aristolochia 
bracteolata.
Phytochemical screening
phytoconstituents detected in plant samples as: ste-
rols,  triterpenes,  alkaloids,  flavonoids,  cardeno-
lides, tannins, saponins, cyanogenic glycosides and 
anthraquinones  are  shown  in  Table  3.  Out  of  the 
10 plant samples tested, none had shown the pres-
ence  of  cyanogenic  glycosides. Alkaloids  and  ste-
rols were detected in 8 plant samples while tannins 
were found to occur in 7 plant samples. Cardenolides 
were detected in trace amounts in 3 plant samples; 
Ambrosia maritima, Citrullus colocynthis and Cro-
ton zambesicus. Flavonoids were evident in 5 plant 
samples while triterpenes were found to exist in only 
2 samples and traces of anthraquinones were detected 
in 2 samples.
Discussion
The present study examined the antiplasmodial activ-
ity of 10 plants used traditionally as crude drug pow-
ders as for Nigella and Pulicaria or in a form of water 
extracts as for others, to treat fever and/or malaria, 
Table . In vitro antiplasmodial activities of extracts from certain sudanese medicinal plants on Plasmodium falciparum.
plant species Maturation of the parasite (%)*
control concentrations used in ug/ml
5 50 500
Aerva javanica 100 88.24   2.35   0.0
Ambrosia maritime 100 35.29 17.65   5.88
Aristolochia bracteo-lata 100 2.35   0.00   0.00
Citrullus colocynthis 100 17.65   3.53   2.35
Croton zambesicus 100 52.94 42.35 17.65
Gardenia lutea 100   4.71   3.53   2.35
Pulicaria crispa 100 58.82 14.12   3.35
Nigella sativa 100   2.35   0.00   0.00
Solenostema argel 100   6.06   4.71   1.18
Tinospora bakis 100 72.94 29.41   7.06
chloroquine concentration used in ug/ml
0.2 0.4 0.8 1.6 3.2
100 76 8.24 1.18 0.0 0.0
*In relation to negative control, the difference being statistically significant (p  0.01).sudanese antiplasmodial medicinal plants
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on the number of developed schizonts expressed in 
maturation percentage of the parasite (Table 2).
The in vitro test results (Table 2), also showed 
that,  significantly  higher  amounts  of  plant  drugs 
were  required,  as  compared  with  positive  control 
drugs represented by the standard antimalarial chlo-
roquine. However, these plant drugs could be con-
sidered  as  active  antimalarial  drugs,  since  plant 
extracts  are  considered  active  if  they  demonstrate 
50% growth inhibition of the parasite at concentra-
tion 50 µg/ml.8 Moreover, in all of the plant extracts 
more than 50% inhibition of the parasites at concen-
tration 50 µg/ml was obtained, indicating that, such 
antiplasmodial activity of these plants have proven 
the ethomedical claims to treat fever and/or malaria. 
Nigella sativa seeds are edible and used widely as 
condiment and/or spice.9 Thus, it has the advantage 
as crude antimalarial over Aristoloshia species which 
had been shown to be nephrotoxic, mutagenic and 
carcinogenic due to the cytotoxicity of the aristolo-
chic acid constituents.10,11
Hence the use of Aristolochia bracteolata as an 
antimalarial plant is not recommended in its crude 
form. However, the antimalarial activity may reside 
in a nontoxic molecule which needs to be investi-
gated. The antiplasmodial activity was not confined 
to any particular family and not restricted to any mor-
phological part of the plant. Nonetheless, we believe 
that studies on these plants concerning their toxicity, 
teratogenicty,  carcinogenicity  and  other  biological 
evaluation should be pursued to end with safe and 
effective affordable drug.
The  preliminary  phytochemical  screening  of 
plants  under  investigation  (Table  3),  revealed  that 
none of them had shown the presence of cyanogenic 
glycosides. The tituents was found two plants which 
showed  high  antiplasmodial  activity  (50  µg/ml), 
Nigella  sativa  and  Aristolochia  brateolata  showed 
the presence of sterols, alkaloids and tannins. It was 
noticed that in all plant samples more than one group 
of constituents were found in each morphological part 
tested. Physiological activity may be due to one or 
more than one group of constituents. Several investi-
gations have been published in the field of antiplas-
modials of plant origin related to different bioaditive 
functional groups classified as: terpenoids;3–5,12 alka-
loids;3,13–16 unsaturated fatty acids;17 volatile oils18,19 
and phenolic compounds including flavonoids4,17 and 
quinones.20,21
In conclusion, we have demonstrated the antima-
larial effects and preliminary phytochemical profiles 
of extracts from ten commonly used Sudanese medic-
inal plants. Effort will be undertaken to continue bio-
logical and phytochemical evaluation to isolate and 
identify the active constituents as well as to under-
stand the mechanism of action.
Table . Plants screened for their phytoconstituents.
no. Botanical name plant 
part 
tested
sterols Triter 
penes
Alkaloids Flavon 
oids
carden 
olides
Tan nins sapo 
nins
cyanog 
enic 
glycosides
Anthraquin 
ones
1 Aerva  
Javanica
WP – – ± + – + – – –
2 Aristolochia 
bracteolata
WP + – + – – ± – – –
3 Solenostema argel L + – ± ± – + ± – –
4 Pulicaria crispa WP ± – – + – ± + – –
5 Ambrosia maritima WP + – + – ± – – – –
6 Citrullus colocynthis s ± ± ± ± ± – ± – –
7 Croton zambesicus Fr ± – – – ± + – – –
8 Tinospora bakis WP – – + – – + – – –
9 Nigella sativa s + ± ± + – + + – ±
10 Gardenia lutea FrP ± + ± – – – + – –
Abbreviations: L, leaf; WP, whole plant; Fr, fruit; FrP, fruit pulp; s, seed; –, negative test (not detected); ±, slightly positive test (traces); +, strongly 
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